Memory Pharmaceuticals Achieves Milestone in PDE10 Collaboration With Amgen

Amgen Also Increases Research Funding Commitment for Collaboration ... MONTVALE, N.J., September 28 /Impact Wire/ -- Memory Pharmaceuticals Corp. (MEMY) today announced that it has achieved a $2.0 million milestone related to its PDE10 collaboration with Amgen, a... [read full story]                    

Add Comment
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies